Researchers at the Case Western Reserve University School of Medicine
Read moreHome »
AbbVie Announces Patient-Reported Outcomes Data from Three Pivotal Phase 3 Studies of Risankizumab, Showing Significant Improvements in Health-Related Quality of Life for Patients with Psoriasis
NORTH CHICAGO, Ill., Sept. 13, 2018 /PRNewswire/ — AbbVie (NYSE:
Read moreSexual Minorities Have Lower Health-Related Quality of Life
FRIDAY, Aug. 10, 2018 — Sexual minority women and men
Read more